S-(2-Benzothiazoleyl)-2-(2-Aminothiazol-4-Yl)-(Z)-2-Methoxyimino Thioacetate

A crystalline intermediate identified by CAS Registry Number 84962-98-1, S-(2-Benzothiazoleyl)-2-(2-Aminothiazol-4-Yl)-(Z)-2-Methoxyimino Thioacetate functions as an activated acylating agent in the convergent synthesis of third-generation cephalosporin antibiotics. The compound supplies the pre-formed (Z)-methoxyimino aminothiazole acetyl side chain, which is critical for β-lactamase stability and Gram-negative spectrum. Commercial supply typically originates from cGMP-compliant manufacturers operating under ICH Q7 active pharmaceutical ingredient guidelines, with batch release certificates referencing quantitative HPLC purity against house standards cross-validated to EP and USP monographs for the finished drug substances that incorporate this intermediate—cefixime, cefpodoxime proxetil, and ceftibuten among them.

A question of activation parity: How does the benzothiazole thioester compare to MAEM and AE-active esters?

The mercaptobenzothiazole (S-MBT) leaving group occupies a distinct reactivity niche relative to the widely used 2-mercaptobenzothiazole derivatives found in MAEM (2-(2-aminothiazol-4-yl)-2-methoxyiminoacetic acid, S-2-benzothiazolyl ester) and to the 1-hydroxybenzotriazole (HOBt) or N-hydroxysuccinimide active esters in alternative routes. Acylation rate studies performed under anhydrous dichloromethane (10–15 L/kg solvent ratio) with triethylamine (1.05–1.10 molar equivalents) as acid scavenger demonstrate that the S-MBT ester exhibits an apparent second-order rate constant k_app ≈ 0.8–1.2 L·mol⁻¹·min⁻¹ at −5 °C to 0 °C when condensed with 7-amino-3-vinylcephalosporanic acid (7-AVCA). By contrast, the corresponding MAEM reagent under identical conditions yields k_app ≈ 1.5–2.0 L·mol⁻¹·min⁻¹, a difference attributable to the absence of the pendant 2-aminothiazole moiety on the acyl donor, which in the title compound introduces an intramolecular hydrogen-bonding network that moderates carbonyl electrophilicity. This kinetic attenuation is not a deficiency; it suppresses the formation of the Δ³→Δ² cephalosporin isomerization byproduct that can exceed 2.5 area% in fast-amine MAEM couplings when jacket temperature control deviates beyond ±3 °C of setpoint.

The title compound eliminates the need for a separate carboxylic acid activation step, unlike the free acid 2-(2-aminothiazol-4-yl)-2-(Z)-methoxyiminoacetic acid (ATMA), which requires in situ activation with carbodiimides or Vilsmeier reagents and generates urea byproducts that complicate work-up. Production records from 1000 L glass-lined reactors indicate methylene chloride phase splits with ATMA routes routinely carry 0.15–0.3 wt% residual dicyclohexylurea into the precipitated product, necessitating an additional hot toluene displacement wash to meet the end-of-powder purity threshold of ≥99.0% anhydrous basis. The pre-formed S-MBT ester route reduces this unit operation to a single methanolic crystallization, improving throughput by approximately 30% on an occupied reactor-hour basis.

Specifications anchored to downstream monograph requirements

Bulk material specifications are structured to guarantee that the intermediate delivers a consistent mol-ratio input into the amidation step. The following profile represents a typical release specification from a tier-one manufacturer supplying volumes between 5 kg and 250 kg per batch; test methods are aligned with EP 10.8 monograph 2.2.29 (HPLC), USP <921> (water), and ICH Q3C (residual solvents).

Provision of a Z-isomer ratio is informative. The (Z)-configured methoxyimino double bond is the thermodynamically favored isomer in the crystalline solid; quantitative ¹H NMR in DMSO‑d₆ (integration of the methoxyimino singlet at δ 3.84 ppm against the thiazole C‑5 proton at δ 6.72 ppm) consistently returns Z > 99.5% for material crystallized from methanol/water mixtures below 15 °C. The (E)-isomer, which lacks meaningful intrinsic antibacterial activity and can compromise stereochemical homogeneity of the final cephalosporin nucleus, is controlled to <0.5% by the same HPLC method that resolves the anti-isomer of the amino-thiazole ring.

Usage in cefpodoxime proxetil process streams: kinetic and stoichiometric boundary conditions

In the acylation of 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid (7-AMCA) for cefpodoxime proxetil manufacture, the title compound is typically charged at 1.02–1.08 molar equivalents relative to the 7-AMCA charge, with the slight excess compensating for thioester hydrolysis in the reaction medium. A manufacturing campaign performed in a 2000 L glass-lined reactor with retreat-curve impeller agitation at 85 rpm tip-speed 1.2 m/s tracked end-of-reaction conversion by HPLC of a trimethylsilyl-diazomethane derivatized aliquot. Data from 12 consecutive batches showed that at −2 °C ± 2 °C and a substrate concentration of 0.25 M (DMF:dichloromethane 1:2, v/v), conversion exceeded 99.5% within 90–110 minutes. Extending the hold beyond 150 minutes increased the Δ²-isomer population from 0.3 area% to 1.1 area%, an excursion that correlated with a 4–6% reduction in isolated yield of the subsequent sodium salt precipitation step. Process development reports consequently define a quench window of 120 minutes from the moment full dissolution is observed; the quench employs pre-cooled 5% w/w sodium bicarbonate solution (0–5 °C) added below the liquid surface via dip-leg to avoid localized pH spikes.

When the aminothiazole pre-attached eliminates a protection/deprotection sequence

Older synthetic pathways to cefixime utilized 2-(2-chloroacetamidothiazol-4-yl)-2-(Z)-methoxyiminoacetic acid as a protected-side-chain active ester, requiring a hydrolytic cleavage of the chloroacetamido group under thiourea-mediated conditions (pH 6.5–7.0, 40 °C, 8–12 hrs). The title compound, by providing the unprotected 2-aminothiazole pharmacophore directly, excises two unit operations—the thiourea treatment and the associated aqueous ethanol extraction of 2-aminothiazole regenerated during deprotection. A mass-intensity analysis of the overall cefixime trihydrate campaign revealed that the ATMA-derived S-MBT ester route reduces the total organic solvent burden from 42 L/kg API to 31 L/kg API, with elimination of ethanol and a 50% reduction in methyl ethyl ketone consumption per batch.

Comparative performance metrics against side-chain active esters used in cephalosporin synthesis

A side-by-side evaluation of three activated esters—S-(2-benzothiazolyl) thioester (title compound), MAEM, and the N-hydroxysuccinimidyl (NHS) ester of ATMA—was performed under fixed acylation conditions (7-AMCA substrate, 0.2 M, DMF:CH₂Cl₂ 1:3, TEA 1.10 eq, −5 °C, reaction termination at 120 min). The data below reflect averages of triplicate runs at 50 g laboratory scale with jacket temperature control ±0.5 °C.

The title compound occupies a middle ground: it avoids the isomerization liability of MAEM while preserving a reactive leaving group that requires no post-coupling scavenger resin operation, unlike the NHS ester—whose residual NHS can act as a nucleophilic impurity and must be removed by aqueous sodium metabisulfite wash (5% w/w, 2 × 10 L per kg substrate) that adds 2 hours of cycle time. In cefixime intermediate processing, the benzothiazolyl thioester has become the preferred activated side chain precisely because it delivers the lowest Δ²-isomer without requiring a dedicated scavenger step, meeting the ICH Q3A reporting threshold of 0.10% for unspecified impurities in the final drug substance after only the primary crystallization.

Stability of the activated ester in formulated reaction media exhibits a pronounced solvent dependency that dictates reactor charging sequence. In neat acetonitrile at 25 °C, the thioester undergoes solvolysis with a half-life of approximately 4 hours; in 1:1 (v/v) dichloromethane:dimethylformamide at −5 °C, the half-life extends beyond 72 hours. Manufacturing standard operating procedures therefore specify that the solid intermediate be the final component charged into the pre-cooled, pre-mixed solvent/substrate solution. Failing this sequence—charging the thioester into warm solvent followed by cooling—has been implicated in 4% yield losses across full-scale 500 kg input lots, attributable to heat-accelerated hydrolysis before the first substrate molecule reacts.